Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 17/20 | 0.62 |
| ▸ | MAOB | P27338 | 3/20 | 0.59 |
| ▸ | MAOA | P21397 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | CALML3 | P27482 | 1/20 | 0.48 |
| ▸ | SDHA | P31040 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3155344 | 0.96 | F10 (0.56) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3150267 | 0.94 | F10 (0.69) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3151580 | 0.86 | F10 (0.67) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3151739 | 0.86 | MAOB (0.66) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3151481 | 0.86 | F10 (0.57) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3146099 | 0.86 | MAOB (0.68) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3152820 | 0.86 | F10 (0.68) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3155354 | 0.85 | F10 (0.68) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3154921 | 0.84 | F10 (0.56) | F10MAOBMAOALMNAPTGS1 | |
| SCHEMBL3160117 | 0.81 | F10 (0.54) | F10MAOBMAOALMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1411932-A1 | SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY | Bayer HealthCare AG (DE) | 2004-04-28 | — | — | EP | disclosed |
| WO-2003000256-A9 | SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY | BAYER AG (DE) | 2003-02-06 | — | — | WO | disclosed |
| WO-2003000256-A1 | SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY | BAYER HEALTHCARE AG (DE) | 2003-01-03 | — | — | WO | disclosed |